Volunteers for Investigational Drug for Liver
Recruiting
Study Details
The overall purpose for this study is to find out if the investigational study drug is absorbed or eliminated differently in people with normal liver function compared to people with impaired liver function. Another purpose is to assess the safety and tolerability of the study medication in people with healthy to impaired liver function. This study is for research purposes only and is not intended to treat your liver
disease.
Method of Administration: Single subcutaneous injection
Study Period
• 1 eligibility screening visit
• 8 days and 7 nights in our research facility
• 4 follow-up visits
Qualified participants will receive study medication, study related physical exams and laboratory tests
Compensation
Qualified participants will be compensated up to $4,700 for study-related time and procedures
Eligibility Criteria
• 18 years to 75 years old
• Must have decreased liver function or disease such as fatty liver disease (NASH), Hepatitis C, past history of alcohol related liver disease or cirrhosis
• Volunteers may be taking medicines such as spironolactone (Aldactone®), furosemide (Lasix®), lactulose, or rifaximin (Xifaxan®)
• May also have ascites (fluid in your abdomen) or encephalopathy (brain condition that causes irritability or trouble sleeping)
Research Location:
Share with a Friend
Company Information
Contact Information
Share with a Friend
Other Trials for You
Closed
Featured
BMI: 18-
32
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Closed
BMI: 18-
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Not yet recruiting
Featured
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
Recruiting
Featured
BMI: 65-
85
Volunteer: Healthy
Gender: Man, Woman
Age: 65-
85
Smokers Allowed: No
Recruiting
